PER

1.23%

8.0¢ percheron therapeutics limited

For General Information, page-2195

First 2195 Last

Share
Profile

Follow
schueym99

1,717 Posts.

118

26/06/23

10:40

Post #: 68466827
Share

Originally posted by dalts66: ↑

Wilkie’s powerplay – Antisense, which attracts CSL staff
Wilkie said he caught up with management of biotech Antisense Therapeutics (ASX:ANP) and the company now had a strong line-up of former staff from CSL.

“It’s essentially a new company and loaded with ex-CSL staff now including the board and many of the clinical team,” he said.

“It’s always good to see these movements after having a look under the hood – gives you a little extra confidence.”

He said he is also impressed that former Kazia Therapeutics (ASX:KZA) CEO Dr James Garner has come on as CEO and MD of ANP.

The biotech recently announced recruitment had commenced in its multicentre double-blind, placebo-controlled Phase IIb trial of lead asset ATL1102 in non-ambulant boys with Duchenne muscular dystrophy (DMD).

ANP said the first participant had been randomised and dosed with ATL1102 or Placebo in Turkey.

“We’ve always liked the asset for DMD and they recently dosed the first of 45 boys in the Phase IIb trial so we’ll have newsflow on enrolment coming through as well as some combination study results,” Wilkie said.

The Phase IIb readout is due in mid 2024.

“Yes this one is potentially binary but the upside is multiples from here on success – which we will know in the next 12 to 18 months.

“I like to think of this one as the next Neuren (ASX:NEU).”

Morgans currently have a 12-month price target of 26 cents on ANP with a speculative buy rating. The share price has dropped 40% YTD.

“It’s gone backwards in terms of share price but I don’t think the market has met the team in full yet,” Wilkie said.

“It’s hard to convince CSL scientists to jump ship to a $50m micro-cap,” he said.

Expand

yep. my thoughts exactly as noted on Friday. now we wait....

ANP Price at posting: 6.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

ASX hits all time high out the gate on Friday trades following bullish US inflation data

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

There are more pages in this discussion • 1,332 more messages in this thread...

First 2195 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change -0.001(1.23%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
8.2¢	8.2¢	8.0¢	$63.52K	777.8K

Buyers (Bids)

No.	Vol.	Price($)
2	43377	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.2¢	97561	1

View Market Depth

No.	Vol.	Price($)
2	43377	0.080
2	212658	0.078
1	200000	0.077
3	91500	0.076
4	206988	0.075

Price($)	Vol.	No.
0.082	97561	1
0.083	214000	1
0.084	67142	2
0.085	141000	2
0.086	106100	2

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PER (ASX) Chart

For General Information, page-2195

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For General Information, page-2195

Top Stories

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News